Crescent Biopharma, Inc.CBIONASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank36
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-356.41%
↑ 99% vs avg
Percentile
P36
Within normal range
Streak
1 yr
Consecutive declineStrong
Average
-63192.50%
Historical baseline
PeriodValueYoY Change
TTM-356.41%-
20240.00%+100.0%
2023-391213.55%-521.7%
2022-62927.65%-1055.1%
2021-5447.87%-980.6%
2020-504.17%-
20190.00%-
20180.00%-
20170.00%+100.0%
2016-171475.38%-